TY - JOUR
T1 - The NH2-Terminal region of streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice
AU - Penfound, Thomas A.
AU - Ofek, Itzhak
AU - Courtney, Harry S.
AU - Hasty, David L.
AU - Dale, James B.
N1 - Funding Information:
Departments of 1Medicine, 2Molecular Sciences, and 3Anatomy and Neurobiology, University of Tennessee Health Science Center, and 4Research and Development Service, Veterans Affairs Medical Center, Memphis, Tennessee; and 5Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel
Funding Information:
Financial support: National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Public Health Service (grants AI10085 and AI60592 to J.B.D.) and Department of Veterans Affairs (grants to J.B.D., D.L.H., and H.S.C.).
Funding Information:
Potential conflicts of Interest: J.B.D. is the inventor of certain technologies related to the development of M protein–based group A streptococcal vaccines; these technologies have been licensed from the University of Tennessee Research Foundation to Vaxent, in which J.B.D. has a financial interest and serves as chief scientific officer. All other authors report no potential conflicts.
PY - 2010/5/15
Y1 - 2010/5/15
N2 - Background. The NH2-terminal sequence of the M protein from group A streptococci defines the serotype of the organism and contains epitopes that evoke bactericidal antibodies. Methods. To identify additional roles for this region of the M protein, we constructed a mutant of M5 group A streptococci expressing an M protein with a deletion of amino acid residues 3-22 (ΔNH2). Results. M5 streptococci and the ΔNH2 mutant were resistant to phagocytosis and were similarly virulent in mice. However, ΔNH2 was significantly less hydrophobic, contained less lipoteichoic acid on its surface, and demonstrated reduced adherence to epithelial cells. These differences were abolished when organisms were grown in the presence of protease inhibitors. Treatment with cysteine proteases or with human saliva resulted in the release of M protein from the ΔNH2 mutant at a significantly greater rate than observed with the wild-type M5 strain. Compared with the parent strain, the ΔNH2 strain also showed a significant reduction in its ability to colonize the upper respiratory mucosa of mice. Conclusions. The NH2 terminus of M5 protein has an important role in protecting the surface protein from proteolytic cleavage, thus preserving its function as an anchor for lipoteichoic acid, which is a primary mediator of adherence to epithelial cells and colonization.
AB - Background. The NH2-terminal sequence of the M protein from group A streptococci defines the serotype of the organism and contains epitopes that evoke bactericidal antibodies. Methods. To identify additional roles for this region of the M protein, we constructed a mutant of M5 group A streptococci expressing an M protein with a deletion of amino acid residues 3-22 (ΔNH2). Results. M5 streptococci and the ΔNH2 mutant were resistant to phagocytosis and were similarly virulent in mice. However, ΔNH2 was significantly less hydrophobic, contained less lipoteichoic acid on its surface, and demonstrated reduced adherence to epithelial cells. These differences were abolished when organisms were grown in the presence of protease inhibitors. Treatment with cysteine proteases or with human saliva resulted in the release of M protein from the ΔNH2 mutant at a significantly greater rate than observed with the wild-type M5 strain. Compared with the parent strain, the ΔNH2 strain also showed a significant reduction in its ability to colonize the upper respiratory mucosa of mice. Conclusions. The NH2 terminus of M5 protein has an important role in protecting the surface protein from proteolytic cleavage, thus preserving its function as an anchor for lipoteichoic acid, which is a primary mediator of adherence to epithelial cells and colonization.
UR - http://www.scopus.com/inward/record.url?scp=77951923403&partnerID=8YFLogxK
U2 - 10.1086/652005
DO - 10.1086/652005
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 20367460
AN - SCOPUS:77951923403
SN - 0022-1899
VL - 201
SP - 1580
EP - 1588
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 10
ER -